Clinical trial
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent…
NCT00005607 · Robert H. Lurie Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00005607 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus |
| Official title | A Phase II Study of CPT-11 and 5-FU/LCV in Patients With Previously Untreated Gastric Adenocarcinoma |
| Lead sponsor | Robert H. Lurie Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug |
| Interventions | FOLFIRI regimen, fluorouracil, irinotecan hydrochloride, leucovorin calcium |
| Start date | Feb 1, 2000 |
| First posted | Aug 10, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: